CIK 0001720580 · Non-accelerated filer<br>Smaller reporting company
Adicet Bio, Inc.
Sign in to watch- Ticker
- ACET
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 26
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813305277
- Phone
- 617-482-2333
- Business address
- 131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
- Former names
- resTORbio, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-25 | ORBIMED ADVISORS LLC Director | Purchase | +1,841,100 | $2.40 | $4.4M | 7,526,359 |
| 2024-01-25 | ORBIMED ADVISORS LLC Director | Purchase | +242,200 | $2.40 | $581K | 990,254 |
| 2024-01-25 | ORBIMED ADVISORS LLC Director | Purchase | +1,041,700 | $2.40 | $2.5M | 1,255,985 |
| 2024-01-25 | GORDON CARL L Director | Purchase | +1,841,100 | $2.40 | $4.4M | 7,526,359 |
| 2024-01-25 | GORDON CARL L Director | Purchase | +242,200 | $2.40 | $581K | 990,254 |
| 2024-01-25 | GORDON CARL L Director | Purchase | +1,041,700 | $2.40 | $2.5M | 1,255,985 |
| 2024-01-24 | Galimi Francesco SVP & Chief Medical Officer | Shares withheld for taxes | −4,957 | $2.40 | $12K | 75,501 |
| 2024-01-24 | Galimi Francesco SVP & Chief Medical Officer | Grant or award | +26,300 | 101,801 | ||
| 2024-01-24 | Galimi Francesco SVP & Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +288,134 | 288,134 | ||
| 2024-01-24 | Aftab Blake Chief Scientific Officer | Shares withheld for taxes | −3,565 | $2.40 | $9K | 42,811 |
| 2024-01-24 | Aftab Blake Chief Scientific Officer | Grant or award | +19,700 | 62,511 | ||
| 2024-01-24 | Aftab Blake Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +241,173 | 241,173 | ||
| 2024-01-24 | Healey Don Chief Technology Officer | Shares withheld for taxes | −4,870 | $2.40 | $12K | 52,629 |
| 2024-01-24 | Healey Don Chief Technology Officer | Grant or award | +19,700 | 72,329 | ||
| 2024-01-24 | Healey Don Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +211,633 | 211,633 | ||
| 2024-01-24 | Harvey Brian Nicholas Chief Financial Officer | Shares withheld for taxes | −4,320 | $2.40 | $10K | 73,500 |
| 2024-01-24 | Harvey Brian Nicholas Chief Financial Officer | Grant or award | +26,300 | 99,800 | ||
| 2024-01-24 | Harvey Brian Nicholas Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +288,022 | 288,022 | ||
| 2024-01-24 | Schor Chen President & CEO | Shares withheld for taxes | −15,290 | $2.40 | $37K | 138,471 |
| 2024-01-24 | Schor Chen President & CEO | Grant or award | +70,300 | 208,771 |
Page 7 of 15 · 298 trades